The WHO held a press conference about the situation Thursday. Here are five key takeaways: At present no one who is ill is ...

Fabricated” citations that do not reference real academic papers are spreading in the literature, polluting the public record ...

Sanofi asked the FDA to pull teplizumab out of a speedy review voucher program after a political appointee disagreed with ...

Most researchers conduct their more disruptive work early in their careers, but as they age, they tend to abandon that ...

Also, FDA leadership is facing fresh accusations of political interference in drug reviews, AI oncology startups are trying to make cancer care virtual, and scientists are opening up an entirely new ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

The retirement of Luis Rodríguez, who has been part of the Vessel Sanitation Program since 2010 and served as its chief since ...

The Italian firm Angelini Pharma is buying Catalyst Pharmaceuticals, the maker of rare disease drugs, for $4.1 billion.

Scientists are worried that hantaviruses haven’t been as well studied as they ought to be, but not that the MV Hondius cruise ...

Health and Human Services Secretary Robert F. Kennedy Jr. fired around 3,500 workers from the Food and Drug Administration ...

A political appointee gets in the way of a Sanofi drug's approval, and more from STAT's D.C. Diagnosis newsletter.

In this week's Biotech Scorecard newsletter, Adam Feuerstein takes on the company touting gold microdust suspended in water ...